The Complete Dilaudid (Hydromorphone) Buying Guide

What Is Dilaudid?

Dilaudid is the brand name for hydromorphone, a potent semi-synthetic opioid analgesic derived from morphine. It is used for the management of severe pain, particularly when other opioid analgesics are insufficient.

Hydromorphone is approximately 4 to 8 times more potent than morphine on a milligram-for-milligram basis. This high potency makes it effective for severe pain but also increases the risk of serious adverse effects including respiratory depression and overdose.

Dilaudid is available in oral tablets, oral solution, and injectable formulations. It is also available as an extended-release formulation under the brand name Exalgo. It is designated as a Schedule II controlled substance, reflecting its high potential for abuse and dependence.

How Dilaudid Works

Hydromorphone works primarily by binding to mu-opioid receptors in the brain, spinal cord, and other tissues. When activated, these receptors reduce the transmission of pain signals and alter the brain's perception of and emotional response to pain.

Compared to morphine, hydromorphone has a higher binding affinity for mu-opioid receptors and produces more potent analgesia. It has a relatively short half-life of approximately 2-3 hours for immediate-release formulations, which contributes to its rapid onset and high potency.

Hydromorphone is metabolized primarily in the liver to hydromorphone-3-glucuronide, which has some neuroexcitatory effects. Unlike morphine, it does not produce clinically significant active metabolites.

FDA Schedule & Classification

FDA-Approved Uses

Hydromorphone is FDA-approved for the management of pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate.

• Moderate to severe pain: Post-surgical pain, cancer pain, severe injury-related pain, and acute pain in hospital settings.
• Injectable formulations: Frequently used in hospital and emergency department settings for acute severe pain management.
• Exalgo (extended-release): Indicated for around-the-clock management of moderate to severe pain in opioid-tolerant patients.

The lowest effective dose should be used for the shortest duration consistent with treatment goals. Due to its high potency, hydromorphone requires careful dose titration.

Dosage Forms & Strengths

Immediate-Release Oral Tablets

The typical starting dose for opioid-naive patients is 2 mg to 4 mg every 4 to 6 hours as needed for pain. Doses should be titrated individually based on severity of pain and patient response.

Injectable Formulations

Extended-Release (Exalgo)

Extended-release tablets must be swallowed whole and should not be crushed, broken, or chewed. Exalgo is indicated only for opioid-tolerant patients.

Elderly patients and those with hepatic or renal impairment may require significant dose reductions and closer monitoring.

Side Effects

Common Side Effects

• Constipation — the most common side effect; a bowel regimen is often prescribed
• Nausea and vomiting
• Drowsiness and sedation
• Dizziness
• Sweating
• Itching (pruritus)
• Dry mouth
• Headache

Serious Side Effects

Contact your healthcare provider or seek emergency medical attention if you experience:

• Respiratory depression — slow, shallow, or stopped breathing; can be life-threatening, especially at higher doses or when combined with other CNS depressants
• Severe allergic reaction (anaphylaxis) — hives, difficulty breathing, swelling of face/throat
• Severe hypotension — dangerously low blood pressure
• Adrenal insufficiency — chronic use may suppress adrenal function
• Serotonin syndrome — agitation, confusion, rapid heart rate, muscle rigidity (rare)
• Neurotoxicity — hydromorphone-3-glucuronide metabolite may cause seizures or myoclonus with high doses or renal impairment

Drug Interactions

Hydromorphone is metabolized primarily by glucuronidation in the liver. It has fewer CYP450 interactions than some other opioids but still carries significant interaction risks.

Major Interactions (Avoid or Use Extreme Caution)

• Benzodiazepines — concurrent use can cause profound sedation, respiratory depression, coma, and death
• Alcohol — significantly increases sedation and respiratory depression risk; never combine
• Other CNS depressants — muscle relaxants, sleep aids, antihistamines — additive sedation
• Other opioids — concurrent use increases overdose risk
• MAO inhibitors — can cause serotonin syndrome; avoid concurrent use

Moderate Interactions (Monitor Closely)

• CYP3A4 inhibitors (ketoconazole, erythromycin) — may slightly increase hydromorphone levels
• Tricyclic antidepressants — additive CNS depression
• Antihistamines (diphenhydramine) — additive sedation

Dependence and Withdrawal

Hydromorphone carries a significant risk of physical and psychological dependence. Withdrawal symptoms may include:

• Anxiety, restlessness, and irritability
• Muscle aches and pains
• Nausea, vomiting, and diarrhea
• Insomnia
• Goosebumps and sweating
• Rapid heart rate and elevated blood pressure

Do not stop taking hydromorphone abruptly. Tapering should occur under medical supervision.

Precautions & Warnings

• High abuse potential: As a Schedule II opioid with high potency, hydromorphone carries a significant risk of misuse, abuse, and addiction.
• Respiratory depression: The most serious risk. Higher risk at higher doses, in elderly patients, and when combined with other CNS depressants.
• Pregnancy: Prolonged use during pregnancy may result in neonatal opioid withdrawal syndrome. Use only when clearly needed.
• Breastfeeding: Hydromorphone is excreted in breast milk. Use is generally not recommended during breastfeeding.
• Elderly patients: Increased sensitivity to opioids. Start at lower doses and titrate slowly.
• Liver disease: Hydromorphone is metabolized by the liver. Patients with hepatic impairment require dose reduction.
• Kidney disease: Metabolites may accumulate in renal impairment; dose reduction required.
• History of substance use disorder: Increased risk of misuse and dependence. Use with caution and close monitoring.
• Driving and machinery: Hydromorphone causes drowsiness and impairs coordination. Do not drive or operate heavy machinery until you know how this medication affects you.

When to Contact a Clinician

Reach out to your healthcare provider if you experience any of the following:

• Symptoms are not improving or are worsening after starting the medication
• You notice new or unexpected side effects
• You feel you need to take more medication to achieve the same effect (tolerance)
• You are having difficulty functioning at work or home due to sedation
• You are experiencing mood changes, depression, or thoughts of self-harm
• You are pregnant or planning to become pregnant
• You have questions about how long you should take this medication
• You want to stop the medication — never stop abruptly without medical guidance

Seek emergency care immediately if you experience seizures, difficulty breathing, severe allergic reaction, or loss of consciousness.